Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
| SANDOZ IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-23 | 2023-10-31 | 207764 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-05 | 2023-11-03 | 206422 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2023-10-02 | 2024-02-01 | 205797 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-09-19 | 2024-01-09 | 204738 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-08-07 | 2023-08-15 | 201264 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-07-31 | 2024-01-09 | 200534 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| VAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58392 |
| VAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58389 |
| VAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58386 |
| MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
| MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |